PureTech’s LYT-100 holds potential to expand treatment options for idiopathic pulmonary fibrosis:… EP News Bureau Jun 6, 2025 As current IPF treatments face adoption and efficacy challenges, GlobalData highlights LYT-100’s potential to address unmet needs…
Alembic Pharma receives US FDA final approval for Pirfenidone tablets EP News Bureau May 24, 2022 Pirfenidone Tablets are indicated for the treatment of Idiopathic Pulmonary Fibrosis (IPF)
